All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Security
Security
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

financeSaturday, August 15, 2026

AI bubble warnings and rate cut hopes dominate

Today's finance news is split between two camps: those worried the AI boom is a bubble, and those worried the economy is slowing faster than expected. The AI skeptics are getting louder, with 'Big Short' investor Steve Eisman pointing to concentration risk, while Nvidia's disclosure of a $21 billion SpaceX stake adds a new wrinkle. Meanwhile, a surprise drop in retail sales has traders betting on Fed rate cuts.

Sources
+8

AI bubble fears

The AI trade is facing its loudest critics yet, with a famous bear and a new analysis both pointing to cracks in the buildout.

#03gizmodo.comAug 15
0
Anthropic Investors Think It’s Worth $2 Trillion

Anthropic is reportedly targeting a $2 trillion valuation for its October IPO, with some investors suggesting $3 trillion. That's a staggering number for a company projecting $100-120 billion in revenue by end of 2026, and it underscores the froth in AI valuations.

Economic slowdown signals

Fresh data points to a cooling economy, which could shift the Fed's next move.

Also today14

  • The 3 things student-loan borrowers told us are confusing them the most right nowwww.businessinsider.com

    Student-loan borrowers are facing sweeping repayment changes and have reported confusion around three main areas: new repayment plans, billing errors, and the transition back to payments. The article highlights the top concerns borrowers have expressed, including understanding ne

  • U.S. ETF Investors at Odds: Chasing Returns or Playing the Long Game?www.etf.com

    This article analyzes the divergence in U.S. ETF investor behavior, noting that the market is no longer monolithic. It contrasts long-term investors who rely on research supporting buy-and-hold strategies with broad-based, cap-weighted stock and bond ETFs, against other investors

  • Are Bonds Failing Retirees? This Advisor Thinks Sowww.etf.com

    This article promotes an episode of "Behind the Ticker," a podcast hosted by Brad Roth, CIO of Thor Funds. The episode features Raymond Bridges, CPA and Managing Member of Bridges Capital, discussing the Bridges Capital Tactical ETF (BDGS). Bridges argues that retirees should con

  • Nvidia discloses $21 billion stake in SpaceX at end of second quarterwww.cnbc.com

    Nvidia disclosed in an SEC filing that its stake in Elon Musk's SpaceX was worth approximately $21 billion at the end of the second quarter. The chipmaker owns 122.8 million Class A shares in the rocket company, which made its public market debut in June. SpaceX's stock has since

  • Two charts that destroy MAGA economicsohhthatsrich.substack.com

    This opinion piece argues against the MAGA/Republican economic narrative that taxing the wealthy punishes success. The author reframes the debate by examining how wealth is defined and how tax burdens have shifted over time. Using historical data, the article points out that in 1

  • XRP price: Cluster of headwinds gang up on bitcoin and wider crypto marketwww.coindesk.com

    The article reports on headwinds facing XRP, bitcoin, and the wider cryptocurrency market. Key pressures include a deteriorating regulatory picture, continued outflows from spot bitcoin ETFs (with $333 million in net outflows this week, reversing last week's $853 million inflows,

  • FDA approves Bristol multiple myeloma treatment, marking debut of novel drug classwww.statnews.com

    The FDA approved a treatment for advanced multiple myeloma made by Bristol Myers Squibb, marking the debut of a new class of drugs for the blood cancer.

  • Biotech VCs have become like bankers and we might all pay the pricegiftarticle.ft.com

    This opinion piece argues that biotech venture capitalists have shifted from their traditional role of supporting long-term innovation to behaving more like bankers focused on transactions and short-term returns. The author, a San Francisco Bay area physician and entrepreneur, co

More roundups that day